Astera Labs, Inc. $ALAB Stake Lowered by Atreides Management LP

Atreides Management LP trimmed its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 93.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 62,050 shares of the company’s stock after selling 892,733 shares during the quarter. Atreides Management LP’s holdings in Astera Labs were worth $12,149,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also made changes to their positions in the stock. Assetmark Inc. boosted its position in Astera Labs by 374.1% during the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after purchasing an additional 101 shares during the period. Pinpoint Asset Management Singapore Pte. Ltd. acquired a new stake in Astera Labs in the third quarter worth $47,000. Whittier Trust Co. bought a new stake in Astera Labs in the third quarter valued at $55,000. Ramirez Asset Management Inc. acquired a new position in shares of Astera Labs during the third quarter valued at $59,000. Finally, Atlantic Union Bankshares Corp grew its position in shares of Astera Labs by 1,338.1% during the third quarter. Atlantic Union Bankshares Corp now owns 302 shares of the company’s stock worth $59,000 after acquiring an additional 281 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on ALAB shares. Raymond James Financial initiated coverage on shares of Astera Labs in a report on Friday, November 21st. They issued a “hold” rating on the stock. Citigroup decreased their target price on shares of Astera Labs from $275.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, February 11th. Royal Bank Of Canada started coverage on shares of Astera Labs in a research note on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 price target on the stock. Jefferies Financial Group reaffirmed a “buy” rating on shares of Astera Labs in a report on Wednesday, December 3rd. Finally, BNP Paribas Exane initiated coverage on Astera Labs in a research report on Thursday, November 20th. They set an “outperform” rating for the company. Fifteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $202.22.

Insider Transactions at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 94,971 shares of the company’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total value of $11,758,359.51. Following the completion of the sale, the chief operating officer directly owned 1,531,301 shares of the company’s stock, valued at approximately $189,590,376.81. This represents a 5.84% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, General Counsel Philip Mazzara sold 10,000 shares of Astera Labs stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $117.47, for a total transaction of $1,174,700.00. Following the completion of the transaction, the general counsel directly owned 128,084 shares in the company, valued at $15,046,027.48. This represents a 7.24% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 224,292 shares of company stock valued at $27,676,069 in the last quarter. 12.50% of the stock is owned by company insiders.

Astera Labs Stock Performance

Shares of NASDAQ ALAB opened at $120.31 on Friday. Astera Labs, Inc. has a 1 year low of $47.13 and a 1 year high of $262.90. The firm has a market cap of $20.48 billion, a P/E ratio of 98.61, a PEG ratio of 2.37 and a beta of 1.74. The stock has a fifty day moving average price of $147.89 and a two-hundred day moving average price of $168.11.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The company had revenue of $270.58 million for the quarter, compared to the consensus estimate of $249.46 million. During the same quarter in the previous year, the business earned $0.37 EPS. The company’s quarterly revenue was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, research analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.